Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2022.943154
PubMed Identifier: 36059633
Publication URI: http://europepmc.org/abstract/MED/36059633
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in oncology
ISSN: 2234-943X